Culture and Sensitivity Nondihydropyridine calcium channel blockers (non-DHP CCBs) appear to reduce proteinuria in patients with diabetic kidney disease Nondihydropyridine calcium channel blockers ...

A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.

For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), dihydropyridine calcium-channel-blocker (DCCB) ...

Calcium channel blockers (CCBs) are prescribed to treat high blood pressure, chest pain, and irregular heartbeats by reducing calcium flow to the heart and arteries. Common side effects of CCBs ...

Elderly adults with hypertension who are newly prescribed a calcium-channel blocker (CCB), compared to other antihypertensive agents, are at least twice as likely to be given a loop diuretic over the ...

Although blood pressure control is considered the main mechanism for preventing the progression of chronic kidney disease (CKD), angiotensin-converting enzyme inhibitors and angiotensin receptors ...

January 29, 2010 — New results from a major population-based study support the hypothesis that use of calcium channel blockers (CCBs), specifically dihydropyridines, may protect against the ...

A typical pregnancy lasts about 40 weeks. When a woman goes into labor at 37 weeks or earlier, it’s called preterm labor and the baby is said to be premature. Some premature babies need special care ...

Culture and Sensitivity Nondihydropyridine calcium channel blockers (non-DHP CCBs) appear to reduce proteinuria in patients with diabetic kidney disease Nondihydropyridine calcium channel blockers ...